Published in J Antimicrob Chemother on January 18, 2009
Health system challenges and solutions to improving mental health outcomes. Ment Health Fam Med (2011) 1.53
HIV-related stigma within communities of gay men: a literature review. AIDS Care (2011) 1.49
The impact of sexual abuse on female development: lessons from a multigenerational, longitudinal research study. Dev Psychopathol (2011) 1.49
Combination prevention: new hope for stopping the epidemic. Curr HIV/AIDS Rep (2013) 1.36
Mental health and the global agenda: core conceptual issues. Ment Health Fam Med (2011) 1.28
Pain, mood, and substance abuse in HIV: implications for clinic visit utilization, antiretroviral therapy adherence, and virologic failure. J Acquir Immune Defic Syndr (2012) 1.27
Mortality after diagnosis of psychiatric disorders and co-occurring substance use disorders among HIV-infected patients. AIDS Patient Care STDS (2010) 1.04
Pain is independently associated with impaired physical function in HIV-infected patients. Pain Med (2013) 0.97
Routine depression screening in an HIV clinic cohort identifies patients with complex psychiatric co-morbidities who show significant response to treatment. AIDS Behav (2013) 0.92
AIDS-related stigma and mental disorders among people living with HIV: a cross-sectional study in Cambodia. PLoS One (2015) 0.92
Should development agencies care about mental health? Ment Health Fam Med (2011) 0.88
Association between childhood physical abuse, unprotected receptive anal intercourse and HIV infection among young men who have sex with men in Vancouver, Canada. PLoS One (2014) 0.87
Mental health outcomes in HIV and childhood maltreatment: a systematic review. Syst Rev (2012) 0.86
Levels of self-reported depression and anxiety among HIV-positive patients in Albania: a cross-sectional study. Croat Med J (2011) 0.86
The impact of substance use, sexual trauma, and intimate partner violence on sexual risk intervention outcomes in couples: a randomized trial. Ann Behav Med (2013) 0.85
Optimizing ART adherence: update for HIV treatment and prevention. Curr HIV/AIDS Rep (2014) 0.84
A qualitative analysis of the effects of depression and antidepressants on physical and work functioning among antiretroviral therapy clients in Uganda. J Int Assoc Provid AIDS Care (2013) 0.83
Correlates of Adherence among Rural Indian Women Living with HIV/AIDS. J HIV AIDS Soc Serv (2012) 0.82
Depressive symptoms, self-esteem, HIV symptom management self-efficacy and self-compassion in people living with HIV. AIDS Care (2013) 0.81
Prevalence, incidence, and persistence of psychiatric and substance use disorders among mothers living with HIV. J Acquir Immune Defic Syndr (2014) 0.81
Anxiety and Depression: Linkages with Viral Diseases. Public Health Rev (2012) 0.80
A Social-Ecological View of Barriers and Facilitators for HIV Treatment Adherence: Interviews with Puerto Rican HIV Patients. PLoS One (2015) 0.80
Depression Correlates with Increased Plasma Levels of Inflammatory Cytokines and a Dysregulated Oxidant/Antioxidant Balance in HIV-1-Infected Subjects Undergoing Antiretroviral Therapy. J Clin Cell Immunol (2014) 0.79
Validation of the Client Diagnostic Questionnaire to Assess Mental Health in South African Caregivers of Children. Clin Psychol Psychother (2016) 0.79
A randomized controlled trial of an HIV/AIDS Symptom Management Manual for depressive symptoms. AIDS Care (2012) 0.78
The role of chronic pain and current substance use in predicting negative social support among disadvantaged persons living with HIV/AIDS. AIDS Care (2016) 0.77
Factors associated with treatment initiation for psychiatric and substance use disorders among persons with HIV. Psychiatr Serv (2013) 0.77
Cost of Care for HIV-Infected Patients with Co-Occurring Substance Use Disorder or Psychiatric Disease: Report from a Large, Integrated Health Plan. AIDS Res Treat (2014) 0.76
A cross-sectional survey of childhood trauma and compliance with general health care among adult primary care outpatients. Prim Care Companion CNS Disord (2014) 0.75
Reflections on living with HIV over time: exploring the perspective of HIV-infected women over 50. Aging Ment Health (2014) 0.75
World Health Day focus on HIV and depression - a comorbidity with specific challenges. J Int AIDS Soc (2017) 0.75
Quality of life and functioning of Hispanic patients with Major Depressive Disorder before and after treatment. J Affect Disord (2017) 0.75
Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry (1994) 48.75
Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med (2000) 23.10
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet (2008) 12.35
Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis (2006) 7.42
Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry (2001) 7.30
Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA (2001) 5.52
Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry (2001) 5.22
Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS (1999) 4.39
Role of depression, stress, and trauma in HIV disease progression. Psychosom Med (2008) 3.65
Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA (1993) 2.93
Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. J Acquir Immune Defic Syndr (2005) 2.69
STAR*D: what have we learned? Am J Psychiatry (2007) 2.47
The efficacy of an integrated risk reduction intervention for HIV-positive women with child sexual abuse histories. AIDS Behav (2004) 2.35
The Criterion A problem revisited: controversies and challenges in defining and measuring psychological trauma. J Trauma Stress (2007) 2.35
Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr (2008) 2.35
Depression and immunity: a meta-analytic review. Psychol Bull (1993) 2.30
Barriers to antiretroviral adherence: the importance of depression, abuse, and other traumatic events. AIDS Patient Care STDS (2006) 2.30
Trauma, mental health, distrust, and stigma among HIV-positive persons: implications for effective care. Psychosom Med (2008) 2.24
Underdiagnosis of depression in HIV: who are we missing? J Gen Intern Med (2003) 2.21
Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2007) 2.02
Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States. J Acquir Immune Defic Syndr (2006) 2.01
How trauma, recent stressful events, and PTSD affect functional health status and health utilization in HIV-infected patients in the south. Psychosom Med (2005) 1.98
The latent structure of posttraumatic stress disorder: a taxometric investigation of reactions to extreme stress. J Abnorm Psychol (2002) 1.72
Relation of lifetime trauma and depressive symptoms to mortality in HIV. Am J Psychiatry (2007) 1.68
Effects of a coping intervention on transmission risk behavior among people living with HIV/AIDS and a history of childhood sexual abuse. J Acquir Immune Defic Syndr (2008) 1.68
General medical and psychiatric comorbidity among HIV-infected veterans in the post-HAART era. J Clin Epidemiol (2001) 1.67
Posttraumatic stress disorder: etiology, epidemiology, and treatment outcome. Annu Rev Clin Psychol (2006) 1.63
Outcomes from a group intervention for coping with HIV/AIDS and childhood sexual abuse: reductions in traumatic stress. AIDS Behav (2007) 1.62
Effect of individual cognitive behaviour intervention on adherence to antiretroviral therapy: prospective randomized trial. Antivir Ther (2004) 1.51
Re-estimating the prevalence of psychiatric disorders in a nationally representative sample of persons receiving care for HIV: results from the HIV Cost and Services Utilization Study. Int J Methods Psychiatr Res (2002) 1.39
Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care. Neuropsychopharmacology (2007) 1.39
Efficacy of antidepressant medication among HIV-positive individuals with depression: a systematic review and meta-analysis. AIDS Patient Care STDS (2005) 1.33
Primary versus specialty care outcomes for depressed outpatients managed with measurement-based care: results from STAR*D. J Gen Intern Med (2008) 1.28
Understanding the interface of HIV, trauma, post-traumatic stress disorder, and substance use and its implications for health outcomes. AIDS Care (2004) 1.24
Efficacy of group psychotherapy to reduce depressive symptoms among HIV-infected individuals: a systematic review and meta-analysis. AIDS Patient Care STDS (2007) 1.21
Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient population. Psychosom Med (2008) 1.19
Case management for substance abusers with HIV/AIDS: a randomized clinical trial. Am J Drug Alcohol Abuse (2003) 1.13
Predictors of AIDS-related morbidity and mortality in a southern U.S. Cohort. AIDS Patient Care STDS (2007) 1.09
Management of psychiatric disorders in patients infected with human immunodeficiency virus. Clin Infect Dis (2001) 1.09
Validation of a brief screening instrument for substance abuse and mental illness in HIV-positive patients. J Acquir Immune Defic Syndr (2005) 1.09
Screening for psychiatric morbidity in a medical outpatient clinic for HIV infection: the need for a psychiatric presence. Int J Psychiatry Med (1994) 1.09
Antidepressant treatment and adherence to combination antiretroviral therapy among patients with AIDS and diagnosed depression. Psychiatr Q (2008) 1.07
Psychiatric disorder in HIV infection. Aust N Z J Psychiatry (1998) 1.04
Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndrome. Biol Psychiatry (2007) 1.00
Generalist care managers for the treatment of depressed medicaid patients in North Carolina: a pilot study. BMC Fam Pract (2007) 0.99
Improving health outcomes among individuals with HIV, mental illness, and substance use disorders in the Southeast. AIDS Care (2006) 0.94
Psychological distress, killer lymphocytes and disease severity in HIV/AIDS. Brain Behav Immun (2008) 0.89
The relationship between type of mental health provider and met and unmet mental health needs in a nationally representative sample of HIV-positive patients. J Behav Health Serv Res (2004) 0.88
Integrating medical and substance abuse treatment for addicts living with HIV/AIDS: evidence-based nursing practice model. Am J Drug Alcohol Abuse (2003) 0.84
Psychometric detection of fabricated symptoms of posttraumatic stress disorder. Am J Psychiatry (1985) 0.78
A road well traveled (although not yet a super highway). Psychosom Med (2008) 0.77